AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2010
Apr 16, 2010
31982_dirs_2010-04-16_de84704c-74ce-45c3-9295-c2543b7bacaa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2010-04-15
Reporting Person: MARSH JOHN O JR (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-04-15 | Options - right to buy | $2.66 | A | 5000 | Acquired | 2020-04-15 | Common Stock (5000) | Direct |
Footnotes
F1: Exercisable 6 months from date of grant.
More from NOVAVAX INC
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Jan 26